Market Overview

What Caused The Opening Gap In Nektar?

Share:

For real-time updates on NKTR, beat the news and login or try Benzinga Pro.

Nektar Therapeutics (NASDAQ: NKTR) today had a large opening gap of -64.28%.

Photo taken from the Opening Gap Signals tool inside Benzinga Pro.

Why Is NKTR Moving?

Nektar Therapeutics shares are trading lower after the company reported worse-than-expected Q2 sales results. JPMorgan also downgraded the company’s stock from Overweight to Neutral. The company also said it has experienced delays with its bempegaldesleukin program.

Photo taken from the ‘Why Is It Moving?’ Details tool inside Benzinga Pro.

For live updates on NKTR, log in or try Benzinga Pro today.

Latest Ratings for NKTR

DateFirmActionFromTo
Aug 2019MaintainsOutperform
Aug 2019DowngradesBuyNeutral
Aug 2019DowngradesBuyHold

View More Analyst Ratings for NKTR
View the Latest Analyst Ratings

Posted-In: Earnings News Downgrades Intraday Update Analyst Ratings

 

Related Articles (NKTR)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
MUCascendReiterates65.0
ALDRCanaccord GenuityDowngrades20.0
LEGHLake StreetInitiates Coverage On21.0
CHUGoldman SachsUpgrades13.2
STZBMO CapitalMaintains230.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Benzinga's Top Upgrades, Downgrades For August 9, 2019

Twists And Turns: This Week's Wild Ride Swings Through U.K., Italy, China